+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Constellation Pharmaceuticals Inc - Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 30 Pages
  • July 2022
  • GlobalData
  • ID: 5637044
Constellation Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Our summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights


Constellation Pharmaceuticals Inc (Constellation), a subsidiary of MorphoSys US Inc, is a clinical biopharmaceutical company that focuses on the development of novel therapeutics for the treatment of serious unmet medical needs of patients, especially cancers associated with abnormal gene expression. The company’s pipeline products include pelabresib (CPI-0610) for the treatment of patients with myelofibrosis (MF); CPI-0209 for solid tumors and/or hematological malignancies; and CPI-482 for hematological malignancies. It uses integrated epigenetics platform that enables it to validate targets and generate small molecules against the targets that modulate gene expression in tumor and immune cells. The company has operations in the US. Constellation is headquartered in Cambridge, Massachusetts, the US.

Constellation Pharmaceuticals Inc Key Recent Developments


Jan 07, 2022: Constellation Pharmaceuticals Appoints Brendan Delaney as Chief Commercial Officer
Jun 03, 2021: MorphoSys to acquire Constellation Pharmaceuticals for $1.7bn
May 31, 2021: Constellation Pharmaceuticals to Participate in Jefferies Virtual Healthcare Conference
May 10, 2021: Constellation Pharmaceuticals Announces First-Quarter 2021 Financial Results and Provides Business Update
Feb 24, 2021: Constellation Pharmaceuticals announces fourth-quarter and full-year 2020 financial results

Reasons to Buy

  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with Our detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • Constellation Pharmaceuticals Inc - Key Facts
  • Constellation Pharmaceuticals Inc - Key Employees
  • Constellation Pharmaceuticals Inc - Key Employee Biographies
  • Constellation Pharmaceuticals Inc - Major Products and Services
  • Constellation Pharmaceuticals Inc - History
  • Constellation Pharmaceuticals Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Constellation Pharmaceuticals Inc - Business Description
  • R&D Overview
  • Constellation Pharmaceuticals Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Constellation Pharmaceuticals Inc - Strengths
  • Constellation Pharmaceuticals Inc - Weaknesses
  • Constellation Pharmaceuticals Inc - Opportunities
  • Constellation Pharmaceuticals Inc - Threats
  • Constellation Pharmaceuticals Inc - Key Competitors
Section 3 - Company’s Lifesciences Financial Deals and Alliances
  • Constellation Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
  • Constellation Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022
  • Constellation Pharmaceuticals Inc, Recent Deals Summary
Section 4 - Company’s Recent Developments
  • Jan 07, 2022: Constellation Pharmaceuticals Appoints Brendan Delaney as Chief Commercial Officer
  • May 31, 2021: Constellation Pharmaceuticals to Participate in Jefferies Virtual Healthcare Conference
  • May 10, 2021: Constellation Pharmaceuticals Announces First-Quarter 2021 Financial Results and Provides Business Update
  • Feb 24, 2021: Constellation Pharmaceuticals announces fourth-quarter and full-year 2020 financial results
  • Feb 19, 2021: Constellation Pharmaceuticals to Participate in the 10th Annual SVB Leerink Global Healthcare Conference
  • Feb 18, 2021: Constellation Pharmaceuticals to Host Conference Call to Discuss Fourth Quarter 2020 Results
  • Jan 06, 2021: Constellation Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
Section 5 - Appendix
  • Methodology
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Constellation Pharmaceuticals Inc, Key Facts
  • Constellation Pharmaceuticals Inc, Key Employees
  • Constellation Pharmaceuticals Inc, Key Employee Biographies
  • Constellation Pharmaceuticals Inc, Major Products and Services
  • Constellation Pharmaceuticals Inc, History
  • Constellation Pharmaceuticals Inc, Subsidiaries
  • Constellation Pharmaceuticals Inc, Key Competitors
  • Constellation Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
  • Constellation Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2016 to YTD 2022
  • Constellation Pharmaceuticals Inc, Recent Deals Summary
List of Figures
  • Constellation Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2016 to YTD 2022
  • Constellation Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2016 to YTD 2022

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Zenith Epigenetics Ltd
  • Janssen Pharmaceuticals Inc
  • Incyte Corp
  • Imago BioSciences Inc
  • GSK plc
  • Geron Corp
  • CTI BioPharma Corp
  • Checkpoint Therapeutics Inc
  • Celgene Corp
  • Astellas Pharma Inc